BJ Health (02389) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend

Bulletin Express

Mar 09

BJ Health (Holdings) Limited (Stock code: 02389) has scheduled its board meeting for 30 March 2026. Directors will review and approve the Group’s audited financial results for the financial year ended 31 December 2025 and decide on the declaration of a final dividend, if any.

The Board currently comprises eight members: Executive Directors Zhu Shi Xing (Chairman), Liu Xue Heng, Gu Shan Chao and Wang Zheng Chun, alongside Independent Non-Executive Directors Tse Man Kit, Keith, Wu Yong Xin, Zhang Yun Zhou and Yang Xiao Yan.

The announcement was released in Hong Kong on 9 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1146810395"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146810395\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146810395?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146810395","market":"hk","top_or_hot":-1,"title":"BJ Health (02389) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend","media":"Bulletin Express","content":"<p>BJ Health (Holdings) Limited (Stock code: 02389) has scheduled its board meeting for 30 March 2026. Directors will review and approve the Group’s audited financial results for the financial year ended 31 December 2025 and decide on the declaration of a final dividend, if any.</p>\n<p>The Board currently comprises eight members: Executive Directors Zhu Shi Xing (Chairman), Liu Xue Heng, Gu Shan Chao and Wang Zheng Chun, alongside Independent Non-Executive Directors Tse Man Kit, Keith, Wu Yong Xin, Zhang Yun Zhou and Yang Xiao Yan.</p>\n<p>The announcement was released in Hong Kong on 9 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BJ Health (02389) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBJ Health (02389) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-09 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BJ Health (Holdings) Limited (Stock code: 02389) has scheduled its board meeting for 30 March 2026. Directors will review and approve the Group’s audited financial results for the financial year ended 31 December 2025 and decide on the declaration of a final dividend, if any.</p>\n<p>The Board currently comprises eight members: Executive Directors Zhu Shi Xing (Chairman), Liu Xue Heng, Gu Shan Chao and Wang Zheng Chun, alongside Independent Non-Executive Directors Tse Man Kit, Keith, Wu Yong Xin, Zhang Yun Zhou and Yang Xiao Yan.</p>\n<p>The announcement was released in Hong Kong on 9 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02389","symbol_name":"北京健康","start_time":0,"source_url":"","article_id":"1146810395","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146810395","pubTimestamp":1773048195,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BJ Health (Holdings) Limited (Stock code: 02389) has scheduled its board meeting for 30 March 2026. Directors will review and approve the Group’s audited financial results for the financial year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02389":"北京健康"},"translate_title":"北京健康(02389)定于2026年3月30日召开董事会批准2025财年业绩及末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02389":1},"content_text":"BJ Health (Holdings) Limited (Stock code: 02389) has scheduled its board meeting for 30 March 2026. Directors will review and approve the Group’s audited financial results for the financial year ended 31 December 2025 and decide on the declaration of a final dividend, if any.\nThe Board currently comprises eight members: Executive Directors Zhu Shi Xing (Chairman), Liu Xue Heng, Gu Shan Chao and Wang Zheng Chun, alongside Independent Non-Executive Directors Tse Man Kit, Keith, Wu Yong Xin, Zhang Yun Zhou and Yang Xiao Yan.\nThe announcement was released in Hong Kong on 9 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}